PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0023895|liver disease |
| Sentences | 62 |
| PubMedID- 22135029 | It is important to analyse the morphologic spectrum of bile duct changes in non-biliary diseases as a link has been reported between intrahepatic cholangiocarcinoma and chronic liver disease associated with viral hepatitis, metabolic syndromes and with alcohol abuse. |
| PubMedID- 19880582 | Accumulating trans-sectional evidence suggests that the presence of multiple metabolic disorders, including obesity, diabetes, dyslipidemia, hypertension, and ultimately metabolic syndrome, are associated with nonalcoholic fatty liver disease (nafld) (1). |
| PubMedID- 24793377 | In conclusion, in contrast to bpa, bps does not appear to induce the metabolic syndrome that may lead to non-alcoholic fatty liver disease (nafld), in vitro. |
| PubMedID- 24834224 | The mean body mass index of the 22 cases was 31.18 +/-5.7 and non-alcoholic fatty liver disease was associated with the metabolic syndrome in these subjects. |
| PubMedID- 22546752 | Gamma-glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome. |
| PubMedID- 23419204 | Objective: while nonalcoholic fatty liver disease (nafld) is associated with the metabolic syndrome, it is not known if nafld plays an independent role in the atherogenic dyslipidemia phenotype. |
| PubMedID- 26064107 | Other metabolic risk factors, such as the presence of metabolic syndrome, are associated with more severe liver disease [8]. |
| PubMedID- 24141383 | Within the transplant group, there was no significant association between mean telomere length and underlying liver disease or presence of the metabolic syndrome or its constituents. |
| PubMedID- 22824769 | The study therefore highlights the need to educate physicians on how to diagnose cirrhosis non-invasively and correlate features of metabolic syndrome with chronic liver disease. |
| PubMedID- 24531850 | Evolving information suggests that the metabolic syndrome with non-alcoholic liver disease may be an important cause of hcc in addition to viral hepatitis and alcohol-induced liver disease. |
| PubMedID- 23308163 | Hepatic encephalopathy (he) is a neuropsychiatric syndrome that develops in patients with severe liver diseases and/or portosystemic shunt surgery resulting from a serious complication of acute and chronic liver failure [1]. |
| PubMedID- 24765691 | An association of non-alcoholic fatty liver disease with insulin resistant metabolic syndrome and hypothyroidism has been suggested. |
| PubMedID- 19730107 | Background: hepatic encephalopathy (he) is a reversible neuropsychiatric syndrome in patients with liver disease. |
| PubMedID- 21212755 | Nonalcoholic fatty liver disease is associated with the metabolic syndrome. |
| PubMedID- 25988570 | Associations between dietary intake and the presence of the metabolic syndrome in patients with non-alcoholic fatty liver disease. |
| PubMedID- 22808787 | The aim of review: to verify the role of nutrition in development of nonalcoholic fatty liver disease in patients with metabolic syndrome. |
| PubMedID- 25911912 | [characteristics of the gastrointestinal myoelectrical activity in patients with nonalcoholic fatty liver disease associated with metabolic syndrome]. |
| PubMedID- 24000461 | [strengthen the research and management of the relationship of liver diseases with metabolic syndrome]. |
| PubMedID- 24044566 | Serum adiponectin, leptin, resistin and rbp4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease. |
| PubMedID- 21413092 | Obesity, which is related to metabolic syndrome and is associated with liver disease, represents an epidemic problem demanding effective therapeutic strategies. |
| PubMedID- 21760736 | Bio f1b hamsters fed with a high-fat/high-cholesterol diet may thus be a good animal model for research on the treatment of diet-induced metabolic syndrome complicated by nonalcoholic fatty liver disease. |
| PubMedID- 24562590 | Hepatic encephalopathy (he) is a neuropsychiatric syndrome which develops in patients with severe liver diseases and/or portal-systemic shunting. |
| PubMedID- 22884916 | Background: nonalcoholic fatty liver disease is closely associated with metabolic syndrome and cardiovascular disease (cvd). |
| PubMedID- 22912746 | Hepatic encephalopathy (he) is a neuropsychiatric syndrome that develops in patients with severe liver diseases and/or portosystemic shunting (ps) resulted from serious complication of acute and chronic liver failure. |
| PubMedID- 21118396 | Background: moderate alcohol consumption may have certain beneficial effects against non-alcoholic fatty liver disease, which is associated with metabolic syndrome. |
| PubMedID- 22844333 | Nonalcoholic fatty liver disease is associated with metabolic syndrome. |
| PubMedID- 20385429 | Re: soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. |
| PubMedID- 26175982 | Background: nonalcoholic fatty liver disease (nafld) is one of the aspects of metabolic syndrome (mets). |
| PubMedID- 23077931 | The central role of the non alcoholic fatty liver disease in metabolic syndrome. |
| PubMedID- 26120587 | Nonalcoholic fatty liver disease relationship with metabolic syndrome in class iii obesity individuals. |
| PubMedID- 25960770 | A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with non-alcoholic fatty liver disease. |
| PubMedID- 22813407 | Association of nonalcoholic fatty liver disease with metabolic syndrome in indian population. |
| PubMedID- 26399788 | Nonalcoholic fatty liver disease is associated with metabolic syndrome and has the unique characteristic of excess lipid accumulation in liver. |
| PubMedID- 24280560 | Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction. |
| PubMedID- 25926979 | The presence of multiple features of the metabolic syndrome is associated with progressive liver disease [53]. |
| PubMedID- 24665862 | Management of fatty liver disease with the metabolic syndrome. |
| PubMedID- 25430922 | A novel animal model of metabolic syndrome with non-alcoholic fatty liver disease and skin inflammation. |
| PubMedID- 24933975 | [efficiency of ursodeoxycholic acid therapy in non-alcoholic fatty liver disease associated with metabolic syndrome]. |
| PubMedID- 25739820 | Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome. |
| PubMedID- 25738756 | Moreover, metabolic syndrome is intricately associated with non-alcoholic fatty liver disease [2]. |
| PubMedID- 21387764 | [non-alcoholic fatty liver disease (nafld) in patients with metabolic syndrome and type 2 diabetes mellitus. |
| PubMedID- 23624251 | Furthermore, a non-invasive method that allows quantification of specific lipid species could help differentiate patients with lal deficiency from patients with non-alcoholic fatty liver disease (nafld) due to metabolic syndrome. |
| PubMedID- 24665369 | [20] found that serum zag concentrations were the only independent predictor of the number of metabolic syndrome components in patients with nonalcoholic fatty liver disease (nafld) after stepwise linear regression analysis. |
| PubMedID- 20308604 | This study shows the effectiveness and safety of rituximab in mc syndrome with advanced liver disease. |
| PubMedID- 23842720 | Non-alcoholic steatohepatitis (nash) is the progressive phenotype of non-alcoholic fatty liver disease associated with the metabolic syndrome. |
| PubMedID- 23032980 | Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in korean adults. |
| PubMedID- 24142602 | Background and objectives: non-alcoholic fatty liver disease (nafld) is one of the most common metabolic syndromes and is characterized by the accumulation of hepatic triglycerides (tg), which result from an imbalance between uptake, synthesis, export, and oxidation of fatty acids. |
| PubMedID- 23897104 | Background: the association of plasma cardiovascular risk markers and metabolic syndrome (mets) with non-alcoholic fatty liver disease (nafld) has not been well defined. |
| PubMedID- 24845607 | Background & aims: non-alcoholic-fatty-liver disease (nafld) is part of the metabolic syndrome. |
| PubMedID- 23066331 | Fatty liver, including non-alcoholic fatty liver disease, is closely associated with metabolic syndrome (ms). |
Page: 1 2